Perseus Proteomics Inc
TSE:4882

Watchlist Manager
Perseus Proteomics Inc Logo
Perseus Proteomics Inc
TSE:4882
Watchlist
Price: 570 JPY -3.72%
Market Cap: 8.4B JPY
Have any thoughts about
Perseus Proteomics Inc?
Write Note

Intrinsic Value

Perseus Proteomics Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Perseus Proteomics Inc stock under the Base Case scenario is 732.02 JPY. Compared to the current market price of 570 JPY, Perseus Proteomics Inc is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
732.02 JPY
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Perseus Proteomics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Perseus Proteomics Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Perseus Proteomics Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

570 JPY
-3.72%
-3.72%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Perseus Proteomics Inc
JP
Biotechnology
Market Cap
8.4B JPY
IPO
Jun 22, 2021
Employees
21
Japan
Market Cap
8.4B JPY
Industry
Biotechnology
IPO
Jun 22, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Perseus Proteomics Inc

Provide an overview of the primary business activities
of Perseus Proteomics Inc.

What unique competitive advantages
does Perseus Proteomics Inc hold over its rivals?

What risks and challenges
does Perseus Proteomics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Perseus Proteomics Inc.

Provide P/S
for Perseus Proteomics Inc.

Provide P/E
for Perseus Proteomics Inc.

Provide P/OCF
for Perseus Proteomics Inc.

Provide P/FCFE
for Perseus Proteomics Inc.

Provide P/B
for Perseus Proteomics Inc.

Provide EV/S
for Perseus Proteomics Inc.

Provide EV/GP
for Perseus Proteomics Inc.

Provide EV/EBITDA
for Perseus Proteomics Inc.

Provide EV/EBIT
for Perseus Proteomics Inc.

Provide EV/OCF
for Perseus Proteomics Inc.

Provide EV/FCFF
for Perseus Proteomics Inc.

Provide EV/IC
for Perseus Proteomics Inc.

Show me price targets
for Perseus Proteomics Inc made by professional analysts.

What are the Revenue projections
for Perseus Proteomics Inc?

How accurate were the past Revenue estimates
for Perseus Proteomics Inc?

What are the Net Income projections
for Perseus Proteomics Inc?

How accurate were the past Net Income estimates
for Perseus Proteomics Inc?

What are the EPS projections
for Perseus Proteomics Inc?

How accurate were the past EPS estimates
for Perseus Proteomics Inc?

What are the EBIT projections
for Perseus Proteomics Inc?

How accurate were the past EBIT estimates
for Perseus Proteomics Inc?

Compare the revenue forecasts
for Perseus Proteomics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Perseus Proteomics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Perseus Proteomics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Perseus Proteomics Inc compared to its peers.

Compare the P/E ratios
of Perseus Proteomics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Perseus Proteomics Inc with its peers.

Analyze the financial leverage
of Perseus Proteomics Inc compared to its main competitors.

Show all profitability ratios
for Perseus Proteomics Inc.

Provide ROE
for Perseus Proteomics Inc.

Provide ROA
for Perseus Proteomics Inc.

Provide ROIC
for Perseus Proteomics Inc.

Provide ROCE
for Perseus Proteomics Inc.

Provide Gross Margin
for Perseus Proteomics Inc.

Provide Operating Margin
for Perseus Proteomics Inc.

Provide Net Margin
for Perseus Proteomics Inc.

Provide FCF Margin
for Perseus Proteomics Inc.

Show all solvency ratios
for Perseus Proteomics Inc.

Provide D/E Ratio
for Perseus Proteomics Inc.

Provide D/A Ratio
for Perseus Proteomics Inc.

Provide Interest Coverage Ratio
for Perseus Proteomics Inc.

Provide Altman Z-Score Ratio
for Perseus Proteomics Inc.

Provide Quick Ratio
for Perseus Proteomics Inc.

Provide Current Ratio
for Perseus Proteomics Inc.

Provide Cash Ratio
for Perseus Proteomics Inc.

What is the historical Revenue growth
over the last 5 years for Perseus Proteomics Inc?

What is the historical Net Income growth
over the last 5 years for Perseus Proteomics Inc?

What is the current Free Cash Flow
of Perseus Proteomics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Perseus Proteomics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Perseus Proteomics Inc

Current Assets 2.1B
Cash & Short-Term Investments 2.1B
Receivables 37.5m
Other Current Assets 24.5m
Non-Current Assets 42.9m
Other Non-Current Assets 42.9m
Current Liabilities 136.6m
Accrued Liabilities 43.5m
Other Current Liabilities 93.1m
Non-Current Liabilities 216.5m
Other Non-Current Liabilities 216.5m
Efficiency

Earnings Waterfall
Perseus Proteomics Inc

Revenue
108.9m JPY
Cost of Revenue
-11.8m JPY
Gross Profit
97m JPY
Operating Expenses
-961.9m JPY
Operating Income
-864.9m JPY
Other Expenses
-101.5m JPY
Net Income
-966.4m JPY

Free Cash Flow Analysis
Perseus Proteomics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Perseus Proteomics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive 1-Year Revenue Growth
28/100
Profitability
Score

Perseus Proteomics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Perseus Proteomics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Perseus Proteomics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Perseus Proteomics Inc

Wall Street analysts forecast Perseus Proteomics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Perseus Proteomics Inc is 816 JPY with a low forecast of 808 JPY and a high forecast of 840 JPY.

Lowest
Price Target
808 JPY
42% Upside
Average
Price Target
816 JPY
43% Upside
Highest
Price Target
840 JPY
47% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Perseus Proteomics Inc?

Click here to dive deeper.

Dividends

Perseus Proteomics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Perseus Proteomics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Perseus Proteomics Inc stock?

The intrinsic value of one Perseus Proteomics Inc stock under the Base Case scenario is 732.02 JPY.

Is Perseus Proteomics Inc stock undervalued or overvalued?

Compared to the current market price of 570 JPY, Perseus Proteomics Inc is Undervalued by 22%.

Back to Top